ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy (FARN)

200,00
0,00
(0,00%)
Geschlossen 11 Januar 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
200,00
Gebot
190,00
Fragen
210,00
Volumen
9.637
195,00 Tagesbereich 200,00
89,00 52-Wochen-Bereich 306,00
Marktkapitalisierung
Handelsende
200,00
Handelsbeginn
200,00
Letzte Trade
190
@
200
(UT)
Letzter Handelszeitpunkt
Finanzvolumen
19.274p
VWAP
200,00
Durchschnittliches Volumen (3 Mio.)
18.956
Ausgegebene Aktien
104.620.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-6,76
Gewinn pro Aktie (EPS)
-0,3
Erlöse
-
Nettogewinn
-30,94M

Über Faron Pharmaceuticals Oy

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Turku, Fin
Gegründet
-
Faron Pharmaceuticals Oy is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker FARN. The last closing price for Faron Pharmaceuticals Oy was 200,00p. Over the last year, Faron Pharmaceuticals Oy shares have traded in a share price range of 89,00p to 306,00p.

Faron Pharmaceuticals Oy currently has 104.620.000 shares in issue. The market capitalisation of Faron Pharmaceuticals Oy is £209,24 million. Faron Pharmaceuticals Oy has a price to earnings ratio (PE ratio) of -6.76.

FARN Neueste Nachrichten

Faron Pharmaceuticals Oy Faron’s Financial Calendar for 2025

Faron Pharmaceuticals Oy 13 December 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Faron's Financial Calendar for 2025   Company announcement, 13 December 2024 TURKU...

IN BRIEF: Faron Pharmaceuticals shares up as presents data on Bexmab

cals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive ph ...

Faron presents BEXMAB data at ASH Annual Meeting

Faron presents BEXMAB data at ASH Annual Meeting PR Newswire TURKU, Finland, Dec. 10, 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2...

Faron announces promising findings from blood cancer drug trial

Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...

Faron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB Trial

Faron Pharmaceuticals Oy 27 November 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...

Faron Pharmaceuticals Oy Shareholders’ Nomination Board

Faron Pharmaceuticals Oy 05 November 2024   ("Faron" or "the Company")    Composition of Faron Pharmaceutical's Shareholders' Nomination Board   Company Announcement, 5 November 2024   TURKU...

Faron Pharmaceuticals Oy Faron’s Capital Markets Day 2024

Faron Pharmaceuticals Oy 22 October 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")    Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...

Faron Pharmaceuticals Oy Grant of options

Faron Pharmaceuticals Oy 30 August 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Grant of options   Company announcement, August 30, 2024   TURKU, FINLAND - Faron...

Faron Pharma shares surge as US FDA grants fast track designation

Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully adv ...

Faron Pharmaceuticals Oy Faron 2024 Half-Year Financial Results

Faron Pharmaceuticals Oy 27 August 2024   Faron Pharmaceuticals Ltd. ("Faron" or "the Company")   Faron Reports Half-Year Financial Results, 1 January - 30 June 2024     Company Announcement...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-10-4.76190476192102101956987202.14332742DE
432.519.4029850746167.521016510111189.1894671DE
12-14-6.54205607477214214142.518956174.58778448DE
26101102.02020202992339936681164.07164412DE
52-105-34.42622950823053068939146150.3919898DE
156-100-33.3333333333300392.58921446195.26249348DE
260-67.5-25.2336448598267.55608931825293.31135436DE

FARN - Frequently Asked Questions (FAQ)

What is the current Faron Pharmaceuticals Oy share price?
The current share price of Faron Pharmaceuticals Oy is 200,00p
How many Faron Pharmaceuticals Oy shares are in issue?
Faron Pharmaceuticals Oy has 104.620.000 shares in issue
What is the market cap of Faron Pharmaceuticals Oy?
The market capitalisation of Faron Pharmaceuticals Oy is GBP 209,24M
What is the 1 year trading range for Faron Pharmaceuticals Oy share price?
Faron Pharmaceuticals Oy has traded in the range of 89,00p to 306,00p during the past year
What is the PE ratio of Faron Pharmaceuticals Oy?
The price to earnings ratio of Faron Pharmaceuticals Oy is -6,76
What is the reporting currency for Faron Pharmaceuticals Oy?
Faron Pharmaceuticals Oy reports financial results in EUR
What is the latest annual profit for Faron Pharmaceuticals Oy?
The latest annual profit of Faron Pharmaceuticals Oy is EUR -30,94M
What is the registered address of Faron Pharmaceuticals Oy?
The registered address for Faron Pharmaceuticals Oy is JOUKAHAISENKATU 6, INTELLIGATE, TURKU, FIN-20520
What is the Faron Pharmaceuticals Oy website address?
The website address for Faron Pharmaceuticals Oy is www.faronpharmaceuticals.com
Which industry sector does Faron Pharmaceuticals Oy operate in?
Faron Pharmaceuticals Oy operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCGLSealand Capital Galaxy Limited
4,60p
(43,75%)
10,46M
APHAlliance Pharma Plc
61,10p
(37,77%)
39,55M
NFXNuformix Plc
0,065p
(36,84%)
93,97M
PRMProteome Sciences Plc
4,50p
(31,58%)
1,06M
RCGHRc365 Holding Plc
2,10p
(31,25%)
2,88M
NTQEnteq Technologies Plc
0,775p
(-75,00%)
7,81M
JWNGJaywing Plc
0,625p
(-58,33%)
1,91M
MFAIMindflair Plc
0,825p
(-28,88%)
119,03M
WBIWoodbois Limited
0,135p
(-22,86%)
447,57M
GEXGeorgina Energy Plc
6,625p
(-22,06%)
5,72M
TRPTower Resources Plc
0,0395p
(6,76%)
9,11B
NTVONativo Resources Plc
0,002p
(-9,09%)
1,27B
DGIDg Innovate Plc
0,0185p
(0,00%)
544,86M
WBIWoodbois Limited
0,135p
(-22,86%)
447,57M
MSMNMosman Oil And Gas Limited
0,033p
(-2,94%)
445,45M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock